Representative cytokine and cytotoxicity responses to CMV peptides on day 0 and day 7 in one HLA A2+ donor. Representative cytokine and cytotoxicity responses.

Slides:

Advertisements

Similar presentations

D. Negative fraction after isolation of

Advertisements

Supplementary Figure 3 Antigen-specific responses are enhanced by stimulation in an in vitro stimulation (IVS) assay, as well as with stimulation using.

Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells Marie Bleakley,

Melanoma donor (MD) NK cells are functionally impaired/exhausted.

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

Figure 2 Peptide vaccination using TAA-derived long peptides

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1–restricted CD8+ T-cell epitopes by Lorena Passoni, Antonio Scardino, Carla.

Volume 31, Issue 5, Pages (November 2009)

Simultaneous Ex Vivo Expansion of Cytomegalovirus and Epstein-Barr Virus–Specific Cytotoxic T Lymphocytes Using B-Lymphoblastoid Cell Lines Expressing.

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.

CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib–associated renal carcinoma antigens with ubiquitous or restricted.

Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.

Molecular Therapy - Nucleic Acids

HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation.

Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR)

Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia Guenther.

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo by Suzanne M. McGoldrick, Marie E. Bleakley,

Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease Avital.

Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor.

Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens by Jie Yang, Victor M. Lemas, Ian W. Flinn, Chris.

Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells by Martin R. Müller,

J. Joseph Melenhorst, Phillip Scheinberg, Ann Williams, David R

SpA-SEA-D227A-induced CTL lyse MAb-coated EC

The absence of ADCC by nivolumab in vitro.

HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,

Comparison of cytokine profiles induced by ChiLob 7/4 and TLR ligands in ex vivo whole-blood stimulation assays. Comparison of cytokine profiles induced.

The K594ScFv-SEA-D227A fusion protein targets CTL to lyse EA

Volume 42, Issue 5, Pages (May 2015)

Ex vivo IL-6 production. Ex vivo IL-6 production. Human whole blood was stimulated with the indicated doses of the E. coli O113 endotoxin that was used.

Volume 31, Issue 5, Pages (November 2009)

Flow cytometry analysis of TNF-β- and IL-10-producing CD33+ cells.

Hematological alterations after endotoxin injection.

Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.

Volume 117, Issue 6, Pages (December 1999)

A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2−

Profiles of anti-inflammatory cytokines after endotoxin injection.

IRF4 is required for efficient Th1 CD4+ effector cell differentiation.

Volume 13, Issue 2, Pages (February 2006)

Effects of E. coli and S. aureus infection on levels of TNF-α and IL-1β in milk. Effects of E. coli and S. aureus infection on levels of TNF-α and IL-1β.

Mads Hald Andersen, Jürgen C. Becker, Per thor Straten

Ag 85A–specific immune responses.

Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. Increased proinflammatory cytokine production.

IRF4 is required for efficient Th1 CD4+ effector cell differentiation.

PD-1 blockade enhances T-cell function.

Volume 8, Issue 6, Pages (March 1998)

Molecular Therapy - Oncolytics

Transgenic c-Maf mediates upregulation of type 2 cytokines in NOD CD4, but not CD8, cells. Transgenic c-Maf mediates upregulation of type 2 cytokines in.

IL-6 production with increasing doses of endotoxin.

Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.

Intracellular TNF-α and IL-4 expression in gated CD33+ monocytes by three-color flow cytometry. Intracellular TNF-α and IL-4 expression in gated CD33+

Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+

Cytotoxicity of p5399–107-induced CTL cells.

The NTP increases tyrosine phosphorylation of PLC-γ1.

Comparison of OPN production by mature DCs and activated macrophages.

OPN mediates maturation from immature DCs to mature DCs

HLA-A*0201 restriction of SSX2-derived p stimulated CD8+ T-cells.

Effects of intramammary infection with E. coli or S

Flow cytometry analysis of intracellular cytokine expression in control PBMC (left set of panels) and following either PMA-ionomycin activation (middle.

Cytotoxic activity of CD8+ T-cells stimulated with SSX2-derived p

Reproducibility of CD4+ and CD8+ T-cell enumeration with cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of CD4+

IgM-specific immunoblot analysis of different HCMV recombinant antigens with a selected serum sample from an HCMV-seronegative patient with acute EBV-induced.

PD-1 and CD103 are coexpressed on CD8+ T cells but demonstrate distinct mechanisms of regulation. PD-1 and CD103 are coexpressed on CD8+ T cells but demonstrate.

Dot plot comparison of EBNA-1 with recombinant antigens 52/3 (aa 297 to 433 of pUL44) and UL57/3 (aa 545 to 601 of pUL57) of HCMV, containing glycine-rich.

Characterizing an A*1101-restricted SSC-specific CD8+ cytotoxic T-cell clone. Characterizing an A*1101-restricted SSC-specific CD8+ cytotoxic T-cell clone.

Induction of OVA-specific CTLs by DCs

Flow cytometric gating strategy used to identify CD69 surface expression on CD4 (left paired columns) and CD8 (right paired columns) T lymphocytes. Flow.

OPN production by immature DCs and mature DCs treated with PAMPs

The NTP inhibits the AFC response to SRBC

Surface CD4 and CD14 and intracellular TNF-α expression in PBMCs

Presentation transcript:

Representative cytokine and cytotoxicity responses to CMV peptides on day 0 and day 7 in one HLA A2+ donor. Representative cytokine and cytotoxicity responses to CMV peptides on day 0 and day 7 in one HLA A2+ donor. (A) CFC of CD3+ CD8+ lymphocytes from unstimulated PBMC (left panel), or PBMC stimulated with a pp65 HLA A2-restricted-peptide (amino acids 495 to 503, NLVPMVATV) for 6 h on day 0 (middle panel) or 7 days (right panel). (B) Four-hour51Cr release assay of purified CD8+ lymphocytes after 7 days of peptide restimulation in the same donor as in panel A. Target cells were B-LCL or JY cells loaded with HLA A2-restricted peptide, control (ctrl.) peptide (MVATVGGGA), or no peptide. (C) Example of CFC responses to HLA-A2-restricted peptide (left panels) versus HLA B7-restricted peptide (pp65 amino acids 418 to 426, PRVTGGGAM) (right panels) in a second donor who was HLA A2+ B7+, stimulated for 6 h (top panels) or 7 days (lower panels). This donor, although HLA A2+, responded predominantly to the HLA B7-restricted epitope. (D) Four-hour51Cr release assay of purified CD8+ lymphocytes after 7 days of HLA A2-restricted peptide stimulation in the same donor as in panel C. Target cells were B-LCL loaded with HLA A2-restricted or HLA B7-restricted peptide. Results correlated with those obtained by CFC in panel C. Smita A. Ghanekar et al. Clin. Diagn. Lab. Immunol. 2001; doi:10.1128/CDLI.8.3.628-631.2001